ES2019072B3 - 3-(1h-tetrazol-5-il) tien-(2,3-d]pirimidin-4 (3h) onas. - Google Patents

3-(1h-tetrazol-5-il) tien-(2,3-d]pirimidin-4 (3h) onas.

Info

Publication number
ES2019072B3
ES2019072B3 ES87102608T ES87102608T ES2019072B3 ES 2019072 B3 ES2019072 B3 ES 2019072B3 ES 87102608 T ES87102608 T ES 87102608T ES 87102608 T ES87102608 T ES 87102608T ES 2019072 B3 ES2019072 B3 ES 2019072B3
Authority
ES
Spain
Prior art keywords
pirimidin
onas
tien
tetrazole
appropriate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87102608T
Other languages
English (en)
Inventor
Anna P Vinogradoff
Norton P Peet
Shyam Sunder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2019072B3 publication Critical patent/ES2019072B3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
ES87102608T 1986-02-25 1987-02-24 3-(1h-tetrazol-5-il) tien-(2,3-d]pirimidin-4 (3h) onas. Expired - Lifetime ES2019072B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/833,871 US4761474A (en) 1986-02-25 1986-02-25 3-(1H-tetrazol-5-yl)thieno[2,3-d]pyrimidin-4(3H)-ones

Publications (1)

Publication Number Publication Date
ES2019072B3 true ES2019072B3 (es) 1991-06-01

Family

ID=25265486

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87102608T Expired - Lifetime ES2019072B3 (es) 1986-02-25 1987-02-24 3-(1h-tetrazol-5-il) tien-(2,3-d]pirimidin-4 (3h) onas.

Country Status (20)

Country Link
US (1) US4761474A (es)
EP (1) EP0234557B1 (es)
JP (1) JP2514812B2 (es)
KR (1) KR900001549B1 (es)
CN (1) CN1019490B (es)
AT (1) ATE58738T1 (es)
AU (1) AU588434B2 (es)
CA (1) CA1301153C (es)
DE (1) DE3766379D1 (es)
DK (1) DK92787A (es)
ES (1) ES2019072B3 (es)
FI (1) FI85485C (es)
GR (1) GR3002540T3 (es)
HU (1) HU196805B (es)
IL (1) IL81656A0 (es)
NO (1) NO165294C (es)
NZ (1) NZ219390A (es)
PH (1) PH22591A (es)
PT (1) PT84340B (es)
ZA (1) ZA871259B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2677337C2 (ru) * 2016-12-22 2019-01-16 федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный технический университет" N-замещенные N'-(1-алкилтетразол-5-ил)-тринитроацетимидамиды и способ их получения

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2411273A1 (de) * 1974-03-06 1975-09-18 Schering Ag Neue thieno eckige klammer auf 2,3-d eckige klammer zu pyrimidinone und verfahren zu ihrer herstellung
US4054656A (en) * 1975-09-10 1977-10-18 Mead Johnson & Company Thieno[2,3-d]pyrimidine antiallergic agents
FR2401163A1 (fr) * 1977-08-22 1979-03-23 Bristol Myers Co Nouvelles thieno(2,3-d)pyrimidines, leur procede de preparation et medicament anti-allergique les contenant
GB1583679A (en) * 1977-10-11 1981-01-28 Bristol Myers Co Thieno (2,3-d) pyrimidine and other thiophene-derived anti-allergic agents
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
US4644065A (en) * 1984-05-15 1987-02-17 Merrell Dow Pharmaceuticals Inc. Process for the preparation of 4(3H)-quinazolinones
DE3669315D1 (de) * 1985-03-14 1990-04-12 Sankyo Co Phenoxyalkylaminopyrimidinderivate, deren herstellung und diese enthaltende insektizide und akarizide zusammensetzungen.

Also Published As

Publication number Publication date
ATE58738T1 (de) 1990-12-15
GR3002540T3 (en) 1993-01-25
PH22591A (en) 1988-10-17
EP0234557B1 (en) 1990-11-28
CN1019490B (zh) 1992-12-16
NZ219390A (en) 1989-02-24
HU196805B (en) 1989-01-30
JP2514812B2 (ja) 1996-07-10
US4761474A (en) 1988-08-02
FI85485B (fi) 1992-01-15
CA1301153C (en) 1992-05-19
AU588434B2 (en) 1989-09-14
AU6915487A (en) 1987-08-27
HUT45257A (en) 1988-06-28
NO870750L (no) 1987-08-26
CN87100912A (zh) 1987-12-23
EP0234557A1 (en) 1987-09-02
KR870007933A (ko) 1987-09-23
IL81656A0 (en) 1987-09-16
FI870762A0 (fi) 1987-02-23
NO165294B (no) 1990-10-15
ZA871259B (en) 1987-09-30
FI870762A (fi) 1987-08-26
FI85485C (fi) 1992-04-27
DE3766379D1 (de) 1991-01-10
DK92787D0 (da) 1987-02-24
PT84340B (pt) 1989-09-14
NO870750D0 (no) 1987-02-24
NO165294C (no) 1991-01-23
DK92787A (da) 1987-08-26
KR900001549B1 (ko) 1990-03-12
PT84340A (en) 1987-03-01
JPS62198684A (ja) 1987-09-02

Similar Documents

Publication Publication Date Title
AU6787390A (en) Nitrogen-containing spirocycles
ES2090048T3 (es) Derivados de xantina.
NO874302D0 (no) Fremgangsmaate for fremstilling av 4,5-dihydro- og 4,5,6,7-tetrahydro- pyrazolo (1,5-a)pyrimidiner.
ES2128335T3 (es) Derivados de imidazo(1,2-c)quinazolina como antihipertensivos y antidisuricos.
DE3769721D1 (de) 4(3h)-oxo-5,6,7,8-tetrahydropyrido(2,3-d)pyrimidinderivate.
ES2019072B3 (es) 3-(1h-tetrazol-5-il) tien-(2,3-d]pirimidin-4 (3h) onas.
OA09487A (fr) "Procédé de préparation de nouvelles pyrrolo (1,2-a)thiéno (3,2-f) diazépines(1,4)".
ATE41003T1 (de) Tetrazolothienopyridine.
PT87821A (pt) Process for the preparation of 10-propyl-2,8-bis(1h-tetrazol-5-il)-4h,6h-benzo(1,2-b;5,4-b)dypiran-4,6-dione of calcium
FI900787A0 (fi) Menetelmä 1,3-substituoidun tetrahydro-1H-tieno/3,4-d/-imidatsol-2(3H)-on-4-ylideenipentaanihappoesterin valmistamiseksi
FR2342970A1 (fr) Derives de pyrazolo(1,5-a)pyrazolo(4',3': 5,6)pyrido(3,4-e)pyrimidine
MX9203195A (es) Derivados de oxadiazol alquil purina utiles como agentes antitusivos.
GB2004278A (en) Pyrazolo[4,3-e]1,2,4-triazolo [4,3-c]pyrimidine derivatives
ATE63120T1 (de) 4(3h)-oxo-5,6,7,8-tetrahydropyrido(2,3d>pyrimidinderivate.
JPS5259191A (en) Preparation of 2,6-di(halogenophenoxy)-4,8-dipiperidinopyrimido 5,4-d pyrimidines
ATE96439T1 (de) Substituierte imidazo(2,1-b>chinazolin-5(3h)-one und entsprechende tricyclische verbindungen.